The healthcare industry remains stressed despite a marked improvement in the pandemic situation, with patient visits increasing steadily and elective procedures resuming.
Abbott (ABT) bets on product mix to stay strong. Should you buy the stock?
Categories
pharmaceuticals
Infographic: How Tilray (TLRY) performed in Q1 2022
Tilray (NASDAQ: TLRY) reported first-quarter 2022 financial results after the regular market hours on Thursday. Total net revenue increased 43% year-over-year to
Infographic: Highlights of Aurora Cannabis (ACB) Q4 2021 earnings report
Aurora Cannabis, Inc. (NYSE: ACB) on Monday reported a net loss for the fourth quarter of 2021, continuing the recent trend. However,
Trxade Health Inc. (NASDAQ: MEDS) Q3 2021 Research Summary
It is estimated that the North American e-Pharmacy market would grow at a compound annual rate of 14.8% through 2025. In the
Medicure Inc (MPH) Q2 2021 Earnings Call Transcript
Medicure Inc (CVE:MPH) Q2 2021 earnings call dated Aug. 30, 2021. Corporate Participants: Albert D. Friesen -- Chief Executive Officer and Chairman
Mayne Pharma Group Ltd (MYX) Q4 2021 Earnings Call Transcript
Mayne Pharma Group Ltd (ASX:MYX) Q4 2021 earnings call dated Aug. 26, 2021. Corporate Participants: Scott Richards -- Chief Executive Officer and
IPO News: Should you invest in RenovoRx’s upcoming IPO?
As healthcare startups continue to flock to the stock market, extending the hectic activity seen in the first half, the IPO market
Should you buy Agilent Technologies (A) stock ahead of next week’s earnings?
The impact of the COVID crisis on Agilent Technologies, Inc. (NYSE: A), a leading provider of medical diagnostic devices, has been relatively
IPO News: What to look for when Eliem Therapeutics goes public?
Extending the IPO frenzy that sweeped the market in the early part of the year, emerging biotechnology companies continue to flock to
CVS Health Corp. (CVS) Earnings: 2Q21 Key Numbers
VS Health Corporation (NYSE: CVS) reported second-quarter 2021 earnings results today. Total revenues increased 11.1% to $72.6 billion compared to the same
IPO News: What awaits Adagio Therapeutics after stock market debut?
The favorable regulatory environment and convenient options like direct listing continue to lure emerging businesses to the stock market. The latest statistics
IPO News: Here’s everything you need to know about Healthcare Royalty’s upcoming IPO
In the first half of 2021, a record number of private companies entered stock markets in the US, marking a multifold increase
Merck & Co., Inc. (MRK) Q2 2021 Earnings Call Transcript
Merck & Co., Inc. (NYSE: MRK) Q2 2021 earnings call dated Jul. 29, 2021 Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations Robert
Infographic: Highlights of Merck & Co. (MRK)Q2 2021 earnings report
Merck & Co., Inc. (NYSE: MRK) reported earnings and sales for the second quarter of 2021. Worldwide sales edged up 22% year-over-year
Pfizer (PFE) expects to manufacture up to 3 billion doses of COVID vaccine by end of this year
Shares of Pfizer Inc. (NYSE: PFE) were up 3.5% on Wednesday after the pharma giant reported second quarter 2021 revenue and earnings
Pfizer, Inc. (PFE) Q2 2021 Earnings Call Transcript
Pfizer, Inc. (NYSE: PFE) Q2 2021 Earnings call dated Jul. 28, 2021 Corporate Participants: Christopher Stevo -- Senior Vice President, Chief Investor Relations Officer
WCG Clinical IPO: Here’s what you should know before investing in the stock
Of late healthcare firms have been flocking to Wall Street, betting on the booming stock market to take their business expansion to
Teva Pharmaceutical Industries Ltd (TEVA) Q2 2021 Earnings Call Transcript
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q2 2021 earnings call dated Jul. 28, 2021. Corporate Participants: Kevin C. Mannix -- Senior Vice President,
Pfizer Inc. (PFE) Q2 2021 Earnings Call
Pfizer Inc. (NYSE: PFE) Q2 2021 Earnings call dated Jul. 28, 2021 Corporate Participants: Christopher Stevo — Senior Vice President, Chief Investor Relations Officer Albert
Infographic: How Pfizer (PFE) performed in Q2 2021
Pfizer Inc. (NYSE: PFE) reported second quarter 2021 earnings results today. Total revenue increased 92% year-over-year to $19 billion. GAAP net income
IPO Alert: What to look for when Ocean Biomedical goes public
After tech start-ups, the biotechnology industry is keeping the IPO market busy nowadays. It is estimated that Wall Street is headed for